IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Sonja M Kessler; Eva Lederer; Stephan Laggai; Nicole Golob-Schwarzl; Kevan Hosseini; Johannes Petzold; Caroline Schweiger; Robert Reihs; Marlen Keil; Jens Hoffmann; Christian Reinhard Mayr; Tobias Kiesslich; Martin Pichler; Kyung Sik Kim; Hyungjin Rhee; Young Nyun Park; Sigurd Lax; Peter Obrist; Alexandra K Kiemer; Johannes Haybaeck

doi:10.18632/oncotarget.21116

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Sonja M Kessler
, Eva Lederer
, Stephan Laggai
, Nicole Golob-Schwarzl
, Kevan Hosseini
, Johannes Petzold
, Caroline Schweiger
, Robert Reihs
, Marlen Keil
, Jens Hoffmann
, Christian Reinhard Mayr (Co-author)
, Tobias Kiesslich (Co-author)
, Martin Pichler
, Kyung Sik Kim
, Hyungjin Rhee
, Young Nyun Park
, Sigurd Lax
, Peter Obrist
, Alexandra K Kiemer
, Johannes Haybaeck

Research output: Contribution to journal › Original Article › peer-review

37 Citations (Web of Science)

Original language	English
Pages (from-to)	89736-89745
Journal	Oncotarget
Volume	8
Issue number	52
DOIs	https://doi.org/10.18632/oncotarget.21116
Publication status	Published - 2017

Keywords

MESSENGER-RNA
HEPATOCELLULAR-CARCINOMA
BREAST-CANCER
CELL-ADHESION
V-ATPASE
PROTEIN
SURVIVAL
CHOLANGIOCARCINOMA
OVEREXPRESSION
ADENOCARCINOMA

Access to Document

10.18632/oncotarget.21116

Cite this

Kessler, S. M., Lederer, E., Laggai, S., Golob-Schwarzl, N., Hosseini, K., Petzold, J., Schweiger, C., Reihs, R., Keil, M., Hoffmann, J., Mayr, C. R., Kiesslich, T., Pichler, M., Kim, K. S., Rhee, H., Park, Y. N., Lax, S., Obrist, P., Kiemer, A. K., & Haybaeck, J. (2017). IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. Oncotarget, 8(52), 89736-89745. https://doi.org/10.18632/oncotarget.21116

@article{9c6daa8117d24e58805577fc1bf805a7,

title = "IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.",

keywords = "MESSENGER-RNA, HEPATOCELLULAR-CARCINOMA, BREAST-CANCER, CELL-ADHESION, V-ATPASE, PROTEIN, SURVIVAL, CHOLANGIOCARCINOMA, OVEREXPRESSION, ADENOCARCINOMA",

author = "Kessler, \{Sonja M\} and Eva Lederer and Stephan Laggai and Nicole Golob-Schwarzl and Kevan Hosseini and Johannes Petzold and Caroline Schweiger and Robert Reihs and Marlen Keil and Jens Hoffmann and Mayr, \{Christian Reinhard\} and Tobias Kiesslich and Martin Pichler and Kim, \{Kyung Sik\} and Hyungjin Rhee and Park, \{Young Nyun\} and Sigurd Lax and Peter Obrist and Kiemer, \{Alexandra K\} and Johannes Haybaeck",

note = "Mayr, Kiesslich: Laboratory for Tumor Biology and Experimental Therapies, Institute of Physiology and Pathophysiology, Department of Internal Medicine I, Paracelsus Medical University, Salzburg, Austria",

year = "2017",

doi = "10.18632/oncotarget.21116",

language = "English",

volume = "8",

pages = "89736--89745",

journal = "Oncotarget",

issn = "1949-2553",

number = "52",

}

Kessler, SM, Lederer, E, Laggai, S, Golob-Schwarzl, N, Hosseini, K, Petzold, J, Schweiger, C, Reihs, R, Keil, M, Hoffmann, J, Mayr, CR , Kiesslich, T, Pichler, M, Kim, KS, Rhee, H, Park, YN, Lax, S, Obrist, P, Kiemer, AK & Haybaeck, J 2017, 'IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.', Oncotarget, vol. 8, no. 52, pp. 89736-89745. https://doi.org/10.18632/oncotarget.21116

TY - JOUR

T1 - IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

AU - Kessler, Sonja M

AU - Lederer, Eva

AU - Laggai, Stephan

AU - Golob-Schwarzl, Nicole

AU - Hosseini, Kevan

AU - Petzold, Johannes

AU - Schweiger, Caroline

AU - Reihs, Robert

AU - Keil, Marlen

AU - Hoffmann, Jens

AU - Mayr, Christian Reinhard

AU - Kiesslich, Tobias

AU - Pichler, Martin

AU - Kim, Kyung Sik

AU - Rhee, Hyungjin

AU - Park, Young Nyun

AU - Lax, Sigurd

AU - Obrist, Peter

AU - Kiemer, Alexandra K

AU - Haybaeck, Johannes

N1 - Mayr, Kiesslich: Laboratory for Tumor Biology and Experimental Therapies, Institute of Physiology and Pathophysiology, Department of Internal Medicine I, Paracelsus Medical University, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - MESSENGER-RNA

KW - HEPATOCELLULAR-CARCINOMA

KW - BREAST-CANCER

KW - CELL-ADHESION

KW - V-ATPASE

KW - PROTEIN

KW - SURVIVAL

KW - CHOLANGIOCARCINOMA

KW - OVEREXPRESSION

KW - ADENOCARCINOMA

U2 - 10.18632/oncotarget.21116

DO - 10.18632/oncotarget.21116

M3 - Original Article

C2 - 29163784

SN - 1949-2553

VL - 8

SP - 89736

EP - 89745

JO - Oncotarget

JF - Oncotarget

IS - 52

ER -